PC14586

· PMV Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PC14586, covering 2024-11-13 to 2026-03-12. Get the full timeline:

Most recent: Clinical Trial Update: The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) [Phase 1, Phase 2]

See pricing